You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Gemzar

Showing 26 - 50 of 804
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Cancer Trial in Milwaukee (First-line Chemotherapy, Second-line Chemotherapy, Chemoradiation)

Recruiting
  • Pancreatic Cancer
  • First-line Chemotherapy
  • +2 more
  • Milwaukee, Wisconsin
    Froedtert & the Medical College of Wisconsin
Jul 29, 2022

Adenocarcinoma, Pancreatic Tumors, Tumor, Glandular Trial in Baltimore (Nab-paclitaxel, Gemcitabine, Capecitabine)

Recruiting
  • Adenocarcinoma
  • +9 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Mar 15, 2022

Advanced Pancreatic Cancer Trial in Shanghai (CT-707, Toripalimab, Gemcitabine)

Recruiting
  • Advanced Pancreatic Cancer
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Oct 17, 2022

Advanced Pancreatic Ductal Adenocarcinoma, Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Trial in Boston (AGEN1423,

Not yet recruiting
  • Advanced Pancreatic Ductal Adenocarcinoma
  • +2 more
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Nov 18, 2022

Cholangiocarcinoma Trial in Birmingham (Novel combination of chemo and immunotherapy)

Recruiting
  • Cholangiocarcinoma
  • Novel combination of chemotherapy and immunotherapy
  • Birmingham, Alabama
    University of Alabama at Birmingham
Jul 28, 2022

Sarcoma Trial in Santa Monica (Gemcitabine, Doxorubicin, Docetaxel)

Recruiting
  • Sarcoma
  • Santa Monica, California
    Sant P Chawla
May 4, 2022

Advanced Solid Tumor Trial in Los Angeles, Nashville, Dallas (UCT-01-097, Gemcitabine, Paclitaxel)

Recruiting
  • Advanced Solid Tumor
  • Los Angeles, California
  • +2 more
Sep 8, 2022

KRAS G12V Mutant Advanced Epithelial Cancers Trial (Cyclophosphamide, Gemcitabine, Pembrolizumab)

Available
  • KRAS G12V Mutant Advanced Epithelial Cancers
  • (no location specified)
May 19, 2022

KRAS Activating Mutation, Metastatic Cancer, Pancreas Cancer Trial in Saint Louis (avutometinib (VS-6766) and defactinib in

Recruiting
  • KRAS Activating Mutation
  • +4 more
  • avutometinib (VS-6766) and defactinib in combination with gemcitabine and nab-paclitaxel
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 3, 2023

LMS - Leiomyosarcoma, Uterine Leiomyosarcoma Trial in Stanford (drug, procedure, behavioral)

Suspended
  • LMS - Leiomyosarcoma
  • Uterine Leiomyosarcoma
  • Stanford, California
    Stanford University
Oct 24, 2022

Gallbladder Carcinoma Trial in Shanghai (gemcitabine and oxaliplatin., Afatinib)

Recruiting
  • Gallbladder Carcinoma
  • Shanghai, Shanghai, China
  • +1 more
Dec 21, 2022

Lymphoma, Solid Tumor Trial in Buffalo (Gemcitabine Hydrochloride, Laboratory Biomarker Analysis, Pharmacological Study)

Terminated
  • Lymphoma
  • Solid Neoplasm
  • Gemcitabine Hydrochloride
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 20, 2022

Hodgkin Lymphoma Trial (favezelimab/pembrolizumab, bendamustine, gemcitabine)

Not yet recruiting
  • Hodgkin Lymphoma
  • favezelimab/pembrolizumab
  • +2 more
  • (no location specified)
Aug 18, 2022

Advanced Pancreatic Adenocarcinoma, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Boston (Zentalis, Gemzar)

Not yet recruiting
  • Advanced Pancreatic Adenocarcinoma
  • +2 more
  • Boston, Massachusetts
  • +1 more
Aug 23, 2023

Pancreatic Cancer, Adenocarcinoma of the Pancreas, Adenocarcinoma Trial in New York, Providence (Motixafortide, Cemiplimab,

Recruiting
  • Pancreatic Cancer
  • +2 more
  • New York, New York
  • +1 more
Nov 7, 2022

Pancreatic Ductal Adenocarcinoma Trial in Saint Louis (BMS-813160, Nivolumab, Gemcitabine)

Active, not recruiting
Has Results
  • Pancreatic Ductal Adenocarcinoma
  • Saint Louis, Missouri
    Washington University School of Medicine
Dec 8, 2022

T-cell Non-Hodgkin Lymphoma Trial in Boston (Cyclophosphamide, Doxorubicin, Vincristine)

Terminated
Has Results
  • T-cell Non-Hodgkin Lymphoma
  • Boston, Massachusetts
  • +1 more
Jan 26, 2023

Pancreatic Cancer Trial in Pittsburgh (Gemcitabine, Capecitabine, Stereotactic Body Radiation Therapy (SBRT))

Completed
Has Results
  • Pancreatic Cancer
  • Pittsburgh, Pennsylvania
    UPMC Cancer Centers
Feb 10, 2022

Diffuse Intrinsic Pontine Glioma Trial in Aurora (Gemcitabine)

Recruiting
  • Diffuse Intrinsic Pontine Glioma
  • Aurora, Colorado
    Children's Hospital Colorado
Jan 31, 2022

Lung Cancer Trial in Nashville (Pemetrexed, Gemcitabine)

Completed
Has Results
  • Lung Cancer
  • Nashville, Tennessee
    Tennessee Oncology
Feb 21, 2022

NSCLC Trial in Badalona, Málaga (Docetaxel, Cisplatin, Gemcitabine)

Completed
  • Non-small Cell Lung Cancer
  • Badalona, Barcelona, Spain
  • +1 more
Jun 8, 2022

Non Small Cell Lung Cancer, NSCLC, Small-cell Lung Cancer Trial in Saint Louis (ADI-PEG 20, Gemcitabine, Docetaxel)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • ADI-PEG 20
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 14, 2022

Unresectable Pancreatic Cancer Trial in Milwaukee (Radiation Therapy, Concurrent chemo (Gemcitabine, Capecitabine))

Recruiting
  • Unresectable Pancreatic Cancer
  • Radiation Therapy
  • Concurrent chemotherapy (Gemcitabine, Capecitabine)
  • Milwaukee, Wisconsin
    Froedtert Hospital
Feb 14, 2022

Cholangiocarcinoma, Liver Tumors Trial in Saint Louis (Floxuridine, Dexamethasone, Gemcitabine)

Terminated
  • Cholangiocarcinoma
  • Liver Neoplasms
  • Saint Louis, Missouri
    Washington University School of Medicine
Aug 8, 2022

Diffuse Large B Cell Lymphoma Trial in Saint-Petersburg (Bendamustine HCl, Gemcitabine 500 mg, Gemcitabine 700 mg)

Completed
  • Diffuse Large B Cell Lymphoma
  • Bendamustine hydrochloride
  • +5 more
  • Saint-Petersburg, Russian Federation
    First Pavlov State Medical University of St. Petersburg
Jun 2, 2021